Team Select Scales AI Platform To Full Census, Reports 15% Drop In Hospitalizations
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

Team Select Home Care says its CareSight AI platform now covers 100% of its patient census through respiratory, cardiac and infection models. The company reported a 14.9% year-over-year drop in hospitalization rates from April through August 2026, based on company data; the figures have not been independently verified in the source report.

Team Select Home Care says its predictive AI platform now covers 100% of its patient census, and reports that its hospitalization rate fell 14.9% year over year from April through August 2026. The Phoenix-based provider shared the company’s figures with Home Health Care News; the results matter to its efforts to demonstrate care outcomes to payers, but the reported comparison is not presented as an independently audited evaluation.

The platform, called CareSight AI, uses more than a decade of Team Select patient data. It monitors as many as eight vital signs, along with nursing notes and changes in condition, to flag patterns that could signal a patient’s clinical decline. President and CEO Fred Johnson told Home Health Care News that the system is intended to help clinicians spot trends that may be easy to miss.

CareSight’s coverage expanded through three diagnosis-focused models: respiratory, cardiac and infection detection. Team Select initially built the respiratory model, then added a cardiac model and an infection model after identifying those conditions as important sources of hospitalizations in its data. Johnson said the cardiac model took six months to develop after three years of work on the first model; the infection model took 90 days. The company says every patient is now covered by at least one model.

Team Select compared hospitalization rates from April through August 2026 with the same months in 2025. The company said the rate decreased 14.9% year over year. Johnson also cited an earlier seven-state Medicaid claims study commissioned by Team Select: before CareSight launched, the company’s monthly 30-day hospitalization rate was 3% to 8%, compared with an industry range of 10% to 20% per month. Those figures are attributed to Johnson and the company’s commissioned study, not an independent assessment of CareSight’s effects.

At a glance
reportWhen: Outcome period: April-August 2026; repo…
The developmentTeam Select says it expanded CareSight AI to cover its full patient census and recorded a 14.9% year-over-year decline in hospitalizations over five months.

AI Results Could Shape Payer Deals

The reported decline could give Team Select evidence to support a shift from negotiating only for fee-for-service rate increases toward value-based contracts, in which payment can depend on measured outcomes or total care costs. Johnson said the company hopes to use hospitalization data to pursue additional payer contracts and tie increased reimbursement to reductions in hospital use and overall spending.

The claim also bears on care for medically complex children and seniors, the populations Team Select serves at home. Avoiding an unnecessary hospitalization can matter to patients and families as well as providers and payers. However, the five-month comparison alone does not establish that CareSight caused the decline, or show how the figures translate into patient-level benefits, savings or changes in emergency department visits.

Products Worth Considering

EGO POWER+ Cordless Leaf Blower, 765 CFM, with 5.0Ah Battery (LB7654)

EGO POWER+ Cordless Leaf Blower, 765 CFM, with 5.0Ah Battery (LB7654)

As an affiliate, we earn on qualifying purchases.

From Respiratory Alerts to Census Coverage

Team Select launched CareSight in 2025 after investing $6 million in the platform, according to Home Health Care News. The company first focused on respiratory patients because its leadership viewed that area as a fit for its high-acuity care work. After the initial model, the provider used its data to identify other conditions linked to hospitalizations and extend the system’s coverage.

The company also adjusted how the system handles alerts. Johnson said the first version could flag readings that were unusual by general standards even when they were normal for a particular patient. Team Select added a patient-specific baseline so alerts could be checked against a person’s historical data, which Johnson said reduced false positives and the risk of unnecessary work for clinicians. Team Select operates in 16 states and serves pediatric patients with complex medical needs and seniors in the home.

“I knew that if we could do this, not only would it be a long-lasting competitive advantage … [it] would significantly decrease those hospitalizations even further.”

— Fred Johnson, Team Select Home Care president and CEO, speaking to Home Health Care News

Limits of the Five-Month Comparison

The reported 14.9% decline is based on company data shared with Home Health Care News. The source does not provide patient counts, the underlying calculation, confidence intervals, or a comparison group. It is also unclear whether patient mix, seasonal patterns, staffing, other clinical initiatives or changes in hospital use affected the year-over-year result. The available information therefore does not establish how much, if any, of the change was caused by CareSight.

Team Select’s earlier rate comparison came from a company-commissioned, seven-state Medicaid claims study, according to Johnson. The report does not give enough methodological detail to assess how that study’s population and definitions compare with the 2026 outcome measure. The company has not supplied a payer-by-payer breakdown or disclosed whether the reported decline has already led to new contracts or payment changes.

A Fourth Model in Development

Team Select is developing a fourth CareSight model focused on diabetes, according to the source report. The company is also redeveloping payer scorecards that Johnson said would show measures such as patient satisfaction, hospitalization rates and emergency department visit ratios for each payer’s patients, with industry comparisons.

Further results will be needed to show whether the reported reduction persists beyond the April-August window and whether it is associated with lower total care costs. Details on the diabetes model’s launch date, the scorecards’ availability and any new value-based agreements were not provided in the report.

Key Questions

What is CareSight AI?

CareSight AI is Team Select Home Care’s predictive platform, built using more than a decade of company patient data. It monitors vital signs, nursing notes and changes in condition to flag potential clinical decline.

What hospitalization result did Team Select report?

Team Select reported a 14.9% year-over-year decrease in its hospitalization rate between April and August 2026, compared with the same months in 2025. The figure is based on company data shared with Home Health Care News.

Does the reported decline prove CareSight reduced hospitalizations?

No. The company reported a year-over-year change, but the source does not describe an independent evaluation or comparison group establishing that CareSight caused the decline. Other factors may have contributed.

Which patients are covered by the platform?

Team Select says 100% of its patient census is covered by at least one of its respiratory, cardiac or infection-detection models. The company serves medically complex pediatric patients and seniors in the home.

What is Team Select developing next?

The company is building a fourth model focused on diabetes and redeveloping payer scorecards. The source report did not provide a release date for either initiative.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

8 Wellness Podcasts You Should Listen To Next

Discover eight top wellness podcasts recommended for improving mental and physical health, based on recent expert selections and listener reviews.

Rocket Pharmaceuticals Surges In Global Coverage

Rocket Pharmaceuticals experiences a significant increase in worldwide media mentions, highlighting growing interest in its recent developments.

Bridgebio Pharma Surges In Global Coverage

BridgeBio Pharma experiences a surge in international coverage, with 24 mentions in recent media monitoring, signaling increased global interest.

Health Ventures Surges In Global Coverage

Health Ventures experiences a significant surge in international media coverage, with GDELT reporting seven mentions in a recent window, signaling increased global interest.